Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,952 | 15,508 | 18,291 | 17,529 | 23,479 |
| Marketable Securities | 23,263 | 36,144 | 47,766 | 66,773 | 76,270 |
| Other current assets | 0 | 0 | 0 | 0 | 86 |
| TOTAL | $44,125 | $55,757 | $71,613 | $87,048 | $113,430 |
| Non-Current Assets | |||||
| PPE Net | 58,539 | 60,501 | 62,157 | 65,089 | 67,921 |
| Investments And Advances | 9,253 | 10,750 | 10,746 | 10,736 | 13,441 |
| Other Non-Current Assets | 15,106 | 16,115 | 15,691 | 12,823 | 13,469 |
| TOTAL | $82,898 | $87,366 | $88,594 | $88,648 | $94,831 |
| Total Assets | $127,023 | $143,123 | $160,207 | $175,696 | $208,261 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,001 | 2,235 | 2,983 | 2,884 | 4,335 |
| Accrued Expenses | 6,634 | 5,343 | 5,251 | 6,466 | 20,242 |
| Other current liabilities | 3,613 | 775 | 4,285 | 3,080 | 3,124 |
| TOTAL | $14,248 | $11,559 | $12,519 | $12,430 | $27,701 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10,569 | 10,885 | 11,732 | 11,997 | 12,752 |
| TOTAL | $10,180 | $10,885 | $11,732 | $11,997 | $12,752 |
| Total Liabilities | $24,428 | $22,444 | $24,251 | $24,427 | $40,453 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,509 | 98,483 | 98,367 | 98,308 | 98,674 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -680,574 | -662,191 | -646,550 | -630,969 | -613,786 |
| Other shareholders' equity | -128 | -105 | -53 | -84 | -206 |
| TOTAL | $102,595 | $120,679 | $135,956 | $151,269 | $167,808 |
| Total Liabilities And Equity | $127,023 | $143,123 | $160,207 | $175,696 | $208,261 |